We are a Ukrainian company. We stand with our colleagues, friends, family, and with all people of Ukraine. Learn more
BACK TO GETPROSPECT

Oxford Biomedica

Email address and contacts

Oxford Biomedica company description

Oxford Biomedica (LSE: OXB) is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and a US-based subsidiary, Oxford Biomedica Solutions, based near Boston, MA, US.

  • Employee count

    685

  • Industry

    Biotechnology
  • Headquarters address

    Windrush Court Oxfordshire Oxford

  • Country

    United Kingdom of Great Britain and Northern Ireland

  • Company website

    https://oxb.com

Key Employees

?
************
Validation Specialist
Find Email
A
Alison Howarth
Client Programme Manager
S
Srideep Sarkar Icf Accredited
Director - Learning & Development And Early Career Programme
S
Sarah Barber
Maintenance Manager - Laboratory Assets (Maternity Cover)
N
Nila Nahar
Biotechnologist II
A
Alissa Bray
Principal Scientist
J
José Gonçalves
Senior Scientist - Upstream Process R&D
Sign up to open these and 5 more emails in Oxford Biomedica
Message error line

Oxford Biomedica competitors and alternatives

MiMedx
Biotechnology
762 employees
New England Biolabs
Biotechnology
724 employees
Epredia
Biotechnology
723 employees
Cell Signaling Technology (CST)
Biotechnology
677 employees
MorphoSys
Biotechnology
672 employees
Ambry Genetics
Biotechnology
671 employees
View all competitors

Recently updated team members of Oxford Biomedica

D
Diane Varley
Principal Scientist
K
Kathryn Rowe
Manager, Regulatory Sciences - CMC
E
Ellen Montilla
Business Continuity & Risk Management Lead
L
Léa Ledaine
Cell culture scientist
T
Tina Mistry
Scientist IV
A
Alysa Hawkins
Clinical Analysis Scientist Grade 4
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

50 Free emails every month

Add to Chrome

800+ reviews 90,000+ users

Try email finder for Free and reach your ideal customer